Chronicle Offers Management to Patients With Advanced Signs and Symptoms of Heart Failure (COMPASS-HF)

NACompletedINTERVENTIONAL
Enrollment

277

Participants

Timeline

Start Date

March 31, 2003

Primary Completion Date

June 30, 2005

Study Completion Date

April 30, 2013

Conditions
Heart Failure
Interventions
DEVICE

Chronicle Implantable Hemodynamic Monitor

Surgical implantation of chronic ambulatory implantable hemodynamic monitoring (IHM) device and intracardiac pressure sensing lead. The implantable hemodynamic monitoring device captures intracardiac hemodynamic information about the patient including trended right ventricular (RV) and estimated pulmonary arterial (PA) pressures, heart rate and activity data. The IHM device does not provide therapy, but rather provides intracardiac diagnostic information about the patient which the physician can utilize to manage the patient and the patients heart failure.

OTHER

Standard of Care

Surgical implantation of chronic ambulatory implantable hemodynamic monitoring (IHM) device and intracardiac pressure sensing lead, but physician and patient access to the intracardiac information provided by the device is restricted until the end of the randomized period of the study, at 6 months. Patients and patients heart failure are managed conventionally per standard of care.

Trial Locations (28)

Unknown

University of Alabama at Birmingham, Birmingham

Loma Linda University Medical Center, Loma Linda

UCLA Medical Center, Los Angeles

University of Southern California, Los Angeles

University of Florida - Shands, Gainesville

Crawford LongHospital, Atlanta

Prairie Heart Institute, Springfield

Parkview Memorial Hospital, Fort Wayne

New England Medical Center, Boston

St. Paul Heart, Saint Paul

Mid America Heart Institute, Kansas City

Robert Wood Johnson Medical Center, New Brunswick

Newark Beth Israel, Newark

New York Presbyterian - Columbia, New York

Duke University, Chapel Hill

University of Cincinnati, Cincinnati

The Ohio State University, Columbus

Oklahoma Cardiovascular Associates, Oklahoma City

University of Oklahoma, Oklahoma City

Hospital of the University of Pennsylvania, Philadelphia

Temple University Hospital, Philadelphia

University of Pittsburgh, Pittsburgh

Medical University of South Carolina, Charleston

Baptist Memorial Hospital, Germantown

St. Thomas Hospital, Nashville

St. Luke's Episcopal Hospital/Texas Heart, Houston

LDS Hospital, Salt Lake City

University of Washington Medical Center, Seattle

All Listed Sponsors
lead

Medtronic Cardiac Rhythm and Heart Failure

INDUSTRY

NCT00643279 - Chronicle Offers Management to Patients With Advanced Signs and Symptoms of Heart Failure (COMPASS-HF) | Biotech Hunter | Biotech Hunter